PharmacyCodes



Solfoton Talpheno en es it fr

Solfoton Talpheno Brand names, Solfoton Talpheno Analogs

Solfoton Talpheno Brand Names Mixture

  • No information avaliable

Solfoton Talpheno Chemical_Formula

C12H12N2O3

Solfoton Talpheno RX_link

No information avaliable

Solfoton Talpheno fda sheet

Solfoton Talpheno msds (material safety sheet)

Solfoton_Talpheno MSDS

Solfoton Talpheno Synthesis Reference

Hoerlein, U.S. Pat. 1,025,872 (1912)

Solfoton Talpheno Molecular Weight

232.235 g/mol

Solfoton Talpheno Melting Point

174 oC

Solfoton Talpheno H2O Solubility

<0.01 g/100 mL

Solfoton Talpheno State

Solid

Solfoton Talpheno LogP

1.777

Solfoton Talpheno Dosage Forms

Tablet; Elixir

Solfoton Talpheno Indication

For the treatment of Epilepsy

Solfoton Talpheno Pharmacology

Phenobarbital, the longest-acting barbiturate, is used for its anticonvulsant and sedative-hypnotic properties in the management of all seizure disorders except absence (petit mal).

Solfoton Talpheno Absorption

Absorbed in varying degrees following oral, rectal or parenteral administration. The salts are more rapidly absorbed than are the acids. The rate of absorption is increased if the sodium salt is ingested as a dilute solution or taken on an empty stomach

Solfoton Talpheno side effects and Toxicity

CNS and respiratory depression which may progress to Cheyne-Stokes respiration, areflexia, constriction of the pupils to a slight degree (though in severe poisoning they may wshow paralytic dilation), oliguria, tachycardia, hypotension, lowered body temperature, and coma. Typical shock syndrome (apnea, circulatory collapse, respiratory arrest, and death) may occur.

Solfoton Talpheno Patient Information

PATIENT INFORMATION

Practitioners should give the following information and instructions to patients receiving barbiturates:

1. The use of phenobarbital carries with it an associated risk of psychological and/or physical dependence.
The patient should be warned against increasing the dose of the drug without consulting a physician.

2. Phenobarbital may impair mental and/or physical abilities required for the performance of potentially
hazardous tasks (e.g., driving, operating machinery, etc.).

3. Alcohol should not be consumed while taking phenobarbital. Concurrent use of phenobarbital with other
CNS depressants (e.g., alcohol, narcotics, tranquilizers, and antihistamines) may result in additional CNS
depressant

Solfoton Talpheno Organisms Affected

Humans and other mammals